Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 6796 AL 6810

[Treatment-Quo vadis neurodegeneration?]

Vöglein J, Levin J, Höglinger G.

Nervenarzt. 2023 Oct;94(10):904-912. doi: 10.1007/s00115-023-01544-x. Epub 2023 Oct 6.

Anti-Inflammatory Effect of Traditional Chinese Medicine on the Concept of Mind-Body Interface

Tsai ST, Nithiyanantham S, Satyanarayanan SK, Su KP.

Adv Exp Med Biol. 2023;1411:435-458. doi: 10.1007/978-981-19-7376-5_19.

Strategies for Treatment of Disease-Associated Dementia Beyond Alzheimer's Disease: An Update

Khan SS, Khatik GL, Datusalia AK.

Curr Neuropharmacol. 2023;21(2):309-339. doi: 10.2174/1570159X20666220411083922.

Therapeutic considerations of bioactive compounds in Alzheimer's disease and Parkinson's disease: Dissecting the molecular pathways

Phukan BC, Roy R, Gahatraj I, Bhattacharya P, Borah A.

Phytother Res. 2023 Dec;37(12):5657-5699. doi: 10.1002/ptr.8012. Epub 2023 Oct 12.

Mitochondrial dysfunction and neurological disorders: A narrative review and treatment overview

Alshial EE, Abdulghaney MI, Wadan AS, Abdellatif MA, Ramadan NE, Suleiman AM, Waheed N, Abdellatif M, Mohammed HS.

Life Sci. 2023 Dec 1;334:122257. doi: 10.1016/j.lfs.2023.122257. Epub 2023 Nov 8.

Glutathione-Mediated Neuroprotective Effect of Purine Derivatives

Matsumura N, Aoyama K.

Int J Mol Sci. 2023 Aug 22;24(17):13067. doi: 10.3390/ijms241713067.

Exploring the Potential of Aptamers in Targeting Neuroinflammation and Neurodegenerative Disorders: Opportunities and Challenges

Kong AH, Wu AJ, Ho OK, Leung MM, Huang AS, Yu Y, Zhang G, Lyu A, Li M, Cheung KH.

Int J Mol Sci. 2023 Jul 22;24(14):11780. doi: 10.3390/ijms241411780.

Natural Products-based Drugs: Potential Drug Targets Against Neurological Degeneration

Mittal P, Goyal R, Kapoor R, Wan C, Gautam RK.

Curr Neuropharmacol. 2023;21(4):777-786. doi: 10.2174/1570159X21666230220102605.

Glutamate Receptor Dysregulation and Platelet Glutamate Dynamics in Alzheimer's and Parkinson's Diseases: Insights into Current Medications

Gautam D, Naik UP, Naik MU, Yadav SK, Chaurasia RN, Dash D.

Biomolecules. 2023 Nov 3;13(11):1609. doi: 10.3390/biom13111609.

A Concise Review of Common Plant-derived Compounds as a Potential Therapy for Alzheimer's Disease and Parkinson's Disease: Insight into Structure-Activity-Relationship

Nishal S, Phaugat P, Bazaad J, Dhaka R, Khatkar S, Khatkar A, Khayatkashani M, Alizadeh P, Haghighi SM, Mehri M, Kashani HRK.

CNS Neurol Disord Drug Targets. 2023;22(7):1057-1069. doi: 10.2174/1871527321666220614110616.

Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer's and Parkinson's Diseases

Javed H, Mohamed Fizur NM, Jha NK, Ashraf GM, Ojha S.

Curr Neuropharmacol. 2023;21(6):1421-1432. doi: 10.2174/1570159X21666221223120251.

[Parkinson's disease and Alzheimer type dementia-Pathophysiology and drug treatment approaches]

Dodel R.

Inn Med (Heidelb). 2023 Feb;64(2):113-120. doi: 10.1007/s00108-022-01463-0. Epub 2023 Jan 16.

Brain insulin resistance linked Alzheimer's and Parkinson's disease pathology: An undying implication of epigenetic and autophagy modulation

Kakoty V, Kc S, Kumari S, Yang CH, Dubey SK, Sahebkar A, Kesharwani P, Taliyan R.

Inflammopharmacology. 2023 Apr;31(2):699-716. doi: 10.1007/s10787-023-01187-z. Epub 2023 Mar 23.

Role of Exosomes in the Pathogenesis and Theranostic of Alzheimer's Disease and Parkinson's Disease

He A, Wang M, Li X, Chen H, Lim K, Lu L, Zhang C.

Int J Mol Sci. 2023 Jul 4;24(13):11054. doi: 10.3390/ijms241311054.

Preclinical Evidence-based Review on Therapeutic Potential of Eugenol for the Treatment of Brain Disorders

Goyal A, Solanki A, Verma A.

Curr Mol Med. 2023;23(5):390-400. doi: 10.2174/1566524022666220525145521.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias